Vecuronium Bromide for Injection, a non-depolarizing neuromuscular blocker, is indicated as an adjunct to general anesthesia. Teva announced the reintroduction and availability of Vecuronium Bromide ...
Vecuronium Bromide, a neuromuscular blocker, is indicated as adjunct to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ...
SCHAUMBURG, Ill., Aug. 18, 2011 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of vecuronium bromide for injection, a neuromuscular blocking agent, in 10 and ...
The FDA approved Bridion injections to reverse the effects of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide. Here are seven things to know: 1. Rocuronium bromide and ...
Sagent Pharmaceuticals Inc has expanded a nationwide recall of vecuronium bromide for injection 10 mg, the US Food and Drug Administration (FDA) said today. Vecuronium bromide for injection is a ...
Sun Pharmaceutical Industries, Inc. (SPII), a wholly owned subsidiary of Sun Pharmaceutical Industries, Ltd. is voluntarily recalling three lots of Vecuronium Bromide for Injection, 10 mg (lyophilized ...
January 13, 2012 — The US Food and Drug Administration (FDA) yesterday issued an updated guidance on voluntary product recalls involving Bedford Laboratories injection drugs that were initially made ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results